Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Butzkueven H
276  Ergebnisse:
Personensuche X
?
1

Speech metrics, general disability, brain imaging and quali..:

Noffs, G. ; Boonstra, F. M. C. ; Perera, T....
European Journal of Neurology.  28 (2020)  1 - p. 259-268 , 2020
Link: https://doi.org/10.1111/..
 
?
2

Multiple sclerosis registries in Europe – An updated mappin..:

Glaser, A. ; Stahmann, A. ; Meissner, T....
Multiple Sclerosis and Related Disorders.  27 (2019)  - p. 171-178 , 2019
Link: https://doi.org/10.1016/..
 
?
3

PND13 - REAL WORLD EVIDENCE (RWE) ON IMPACT OF AGE ON LONG-..:

Schulz, M ; Arora, B ; Spelman, T...
Value in Health.  21 (2018)  - p. S331 , 2018
Link: https://doi.org/10.1016/..
 
?
4

Monitoring cognitive change in multiple sclerosis using a c..:

De Meijer, L ; Merlo, D ; Skibina, O...
Multiple Sclerosis Journal - Experimental, Translational and Clinical.  4 (2018)  4 - p. 205521731881551 , 2018
Link: https://doi.org/10.1177/..
 
?
5

PND56 - A COST-EFFECTIVENESS ANALYSIS USING REAL-WORLD DATA..:

Herring, W ; Gould, IG ; Ruiz, L...
Value in Health.  21 (2018)  - p. S338 , 2018
Link: https://doi.org/10.1016/..
 
?
6

PND55 - A COST-EFFECTIVENESS ANALYSIS USING REAL-WORLD DATA..:

Herring, W ; Gould, IG ; Casamassima, G...
Value in Health.  21 (2018)  - p. S338 , 2018
Link: https://doi.org/10.1016/..
 
?
7

PND18 - PROGRESSION OF DISABILITY IN PRIMARY PROGRESSIVE MU..:

Jhuti, GS ; Freitas, R ; Bennett, I...
Value in Health.  21 (2018)  - p. S332 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Anti‐inflammatory disease‐modifying treatment and disabilit..:

Lorscheider, J. ; Kuhle, J. ; Izquierdo, G....
European Journal of Neurology.  26 (2018)  2 - p. 363-370 , 2018
Link: https://doi.org/10.1111/..
 
?
9

Building a global disease cohort for real-work data explora..:

Butzkueven, H.
Journal of the Neurological Sciences.  381 (2017)  - p. 52 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Interleukin-2 receptor-α proximal promoter hypomethylation ..:

Field, J ; Fox, A ; Jordan, M A...
Genes & Immunity.  18 (2017)  2 - p. 59-66 , 2017
Link: https://doi.org/10.1038/..
 
?
11

Real World Evidence (RWE) on Long-Term Persistence of Fingo..:

Schulz, M ; Arora, B ; Walker, R...
Value in Health.  20 (2017)  9 - p. A718-A719 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Natalizumab vs fingolimod in patients with active relapsing..:

Licata, S. ; Butzkueven, H. ; Jeffery, D....
Journal of the Neurological Sciences.  381 (2017)  - p. 246 , 2017
Link: https://doi.org/10.1016/..
 
?
13

First therapy choise in newly diagnosed MS patients: An int..:

Lavorgna, L. ; Bonavita, S. ; Kalincik, T...
Journal of the Neurological Sciences.  381 (2017)  - p. 450 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Risk of early relapse following the switch from injectables..:

Spelman, T. ; Mekhael, L. ; Burke, T....
European Journal of Neurology.  23 (2016)  4 - p. 729-736 , 2016
Link: https://doi.org/10.1111/..
 
?
15

BREMSO: a simple score to predict early the natural course ..:

Bergamaschi, R. ; Montomoli, C. ; Mallucci, G....
European Journal of Neurology.  22 (2015)  6 - p. 981-989 , 2015
Link: https://doi.org/10.1111/..
 
1-15